Manfred Schubert-Zsilavecz

Title: Manfred Schubert-Zsilavecz: Innovator in PPAR-gamma Antagonists

Introduction

Manfred Schubert-Zsilavecz is a notable inventor based in Bad Homburg, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target specific receptors involved in immune responses.

Latest Patents

One of his key patents is for a compound known as E)-2-(5-((4-methoxy-2-(trifluoromethyl)quinolin-6-yl)methoxy)-2-((4-(trifluoromethyl) benzyl)oxy)-benzylidene) hexanoic acid (MTTB). This compound and its derivatives serve as selective peroxisome proliferator-activated receptor gamma (PPAR-γ) antagonists. The invention is particularly relevant for treating immune-related diseases such as systemic inflammation, sepsis, and septic shock. He holds 1 patent related to this innovative work.

Career Highlights

Manfred Schubert-Zsilavecz is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. His work at this institution has allowed him to focus on the development of therapeutic agents that can significantly impact patient care.

Collaborations

Throughout his career, he has collaborated with notable colleagues, including Mario Wurglics and Andreas Von Knethen. These partnerships have enhanced the research and development of new pharmaceutical compounds.

Conclusion

Manfred Schubert-Zsilavecz's contributions to the field of pharmacology, particularly through his patent on PPAR-gamma antagonists, highlight his role as an innovator in medical research. His work continues to pave the way for advancements in the treatment of immune-related diseases.